Publications by the researcher in collaboration with AMADO ANDRÉS BELMONTE (74)

2026

  1. Diagnostic Performance of Two Different Techniques to Quantify CMV-Specific Cell-Mediated Immunity in Intermediate-Risk Seropositive Kidney Transplant Recipients

    Transplant Infectious Disease, Vol. 28, Núm. 1

  2. Evaluation of an Immune-guided Prevention Strategy Against CMV Among Intermediate-risk Kidney Transplant Recipients: A Quasi-experimental Study

    Transplantation, Vol. 110, Núm. 6, pp. e1265-e1275

  3. Infectious Complications in Living Donation Versus Donation After Brain Death Kidney Transplantation

    Transplant Infectious Disease

  4. Real-life experience with maribavir for the treatment of cytomegalovirus infection in solid organ transplant recipients

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 44, Núm. 5

2025

  1. CTLA4 Single-Nucleotide Polymorphisms Influence the Risk of HSV and VZV Infection in Kidney Transplant Recipients: A Prospective Cohort Study

    Transplant International, Vol. 38

  2. Human Cytomegalovirus Infection Induces Long-Term Changes in the Cytokine Milieu of Kidney Transplant Recipients

    Journal of Medical Virology, Vol. 97, Núm. 1

  3. Infection Risk in Older Kidney Transplant Recipients: An Analysis in the Era of Expanded Age Limits

    Transplant International, Vol. 38

  4. Knowledge and Adherence to Lifestyle Habits to Prevent Complications Associated With Immunosuppression in Kidney Transplant Recipients: A Single-Center Survey

    Transplant Infectious Disease, Vol. 27, Núm. 4

  5. Optimizando la adherencia al cribado de infección latente tuberculosa entre receptores de trasplante renal

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 38, Núm. 3, pp. 222-227

2024

  1. Dynamics and Clinical Significance of Cytomegalovirus-Specific Neutralizing Antibodies in Kidney Transplant Recipients Treated with T-Cell–Depleting Agents

    Journal of Infectious Diseases, Vol. 229, Núm. 6, pp. 1812-1816

  2. Human microRNA sequencing and cytomegalovirus infection risk after kidney transplantation

    American Journal of Transplantation, Vol. 24, Núm. 7, pp. 1180-1192

  3. Novel intervention based on an individualized bundle of care to decrease infection in kidney transplant recipients

    Transplant Infectious Disease, Vol. 26, Núm. 6

  4. Performance of a Global Functional Assay Based on Interferon-γ Release to Predict Infectious Complications and Cancer After Kidney Transplantation

    Transplant International, Vol. 37

  5. Severe Presentation of Mpox With Skin, Lung and Pleural Involvement in a Non–HIV-Infected Kidney Transplant Recipient

    American Journal of Kidney Diseases, Vol. 84, Núm. 5, pp. 655-659

  6. Thrombotic microangiopathy after parvovirus B19 infection treatment in a kidney transplant recipient. An uncommon presentation

    Nefrologia

  7. Thrombotic microangiopathy after parvovirus B19 infection treatment in a kidney transplant recipient. An uncommon presentation

    Nefrologia

2023

  1. A joint program of antimicrobial stewardship and hospital-acquired infection control to reduce healthcare-associated infections after kidney transplantation: The Hipomenes study

    American Journal of Transplantation, Vol. 23, Núm. 12, pp. 1949-1960

  2. Cell-mediated and Neutralizing Antibody Responses to the SARS-CoV-2 Omicron BA.4/BA.5-adapted Bivalent Vaccine Booster in Kidney and Liver Transplant Recipients

    Transplantation Direct, Vol. 9, Núm. 10, pp. E1536

  3. Comparison of intracellular cytokine staining versus an ELISA-based assay to assess CMV-specific cell-mediated immunity in high-risk kidney transplant recipients

    Journal of Medical Virology, Vol. 95, Núm. 4

  4. Lung abscess and empyema in a heart transplant recipient from Thailand

    Transplant Infectious Disease, Vol. 25, Núm. 1